Hemachudha Thiravat, Wacharapluesadee Supaporn, Mitrabhakdi Erawady, Wilde Henry, Morimoto Kinjiro, Lewis Richard A
Department of Medicine and the Molecular Biology Laboratory for Neurological Diseases, Chulalongkorn University Hospital, Bangkok 10330, Thailand.
J Neurovirol. 2005 Feb;11(1):93-100. doi: 10.1080/13550280590900409.
Furious rabies is a well-recognized clinical disorder in humans but the paralytic form is not as easily identified. The mechanisms responsible for the weakness and longer survival periods are not clear. Several hypotheses have been proposed, including rabies virus variants associated with a particular vector, location of wounds, incubation period, influence of prior rabies vaccination, and virus localization in the central nervous system (CNS). However, none of these have been substantiated. Regarding molecular analyses of rabies viruses isolated from both furious and paralytic rabies patients, only minor genetic variations with no specific patterns in glyco- (G), phospho- (P), and nucleoprotein (N) sequences have been identified and arginine 333 in G protein was present in all samples. Regional distribution of rabies virus antigenin rabies patients whose survival periods were 7 days or less and magnetic resonance imaging (MRI) of the CNS indicated brainstem and spinal cord as predilection sites regardless of clinical presentations. There are clinical, electrophysiological, and pathological indications that peripheral nerve dysfunction is responsible for weakness in paralytic rabies whereas in furious rabies, even in the absence of clinical weakness, abundant denervation potentials with normal sensory nerve conduction studies and proximal motor latencies suggest anterior horn cell dysfunction. The lack of cellular immunity to rabies virus antigen accompanied by an absence of cerebrospinal fluid (CSF) rabies neutralizing antibody in most paralytic rabies patients may argue against role of an immune response against rabies virus-positive axons. Aberrant immune responses to peripheral nerve antigen, in particular those mediated by one or more cellular-dependent mechanisms, may be involved as is supported by the absence of putative anti-ganglioside antibodies commonly found in immune-mediated peripheral nerve diseases. Longer survival period in paralytic rabies may possibly be related to currently unidentified mechanism(s) on neuronal gene expression, required for virus transcription/replication and for maintaining neuronal survival.
狂躁型狂犬病是一种为人熟知的人类临床病症,但麻痹型狂犬病则不那么容易识别。导致麻痹及较长存活期的机制尚不清楚。人们提出了几种假说,包括与特定传播媒介相关的狂犬病病毒变体、伤口位置、潜伏期、既往狂犬病疫苗接种的影响以及病毒在中枢神经系统(CNS)中的定位。然而,这些假说均未得到证实。关于从狂躁型和麻痹型狂犬病患者中分离出的狂犬病病毒的分子分析,仅在糖蛋白(G)、磷蛋白(P)和核蛋白(N)序列中发现了微小的基因变异,且无特定模式,并且所有样本中G蛋白的第333位氨基酸均为精氨酸。狂犬病患者存活期为7天或更短时间时,狂犬病病毒抗原的区域分布以及中枢神经系统的磁共振成像(MRI)表明,无论临床表现如何,脑干和脊髓都是好发部位。有临床、电生理和病理学迹象表明,外周神经功能障碍是麻痹型狂犬病患者出现麻痹的原因,而在狂躁型狂犬病中,即使没有临床麻痹症状,感觉神经传导研究和近端运动潜伏期正常但出现大量失神经电位,提示前角细胞功能障碍。大多数麻痹型狂犬病患者缺乏针对狂犬病病毒抗原的细胞免疫,同时脑脊液(CSF)中缺乏狂犬病中和抗体,这可能与针对狂犬病病毒阳性轴突的免疫反应作用相悖。对外周神经抗原的异常免疫反应,特别是由一种或多种细胞依赖性机制介导的反应,可能参与其中,这得到了免疫介导的外周神经疾病中常见的假定抗神经节苷脂抗体缺失的支持。麻痹型狂犬病较长的存活期可能与目前尚未明确的神经元基因表达机制有关,这些机制是病毒转录/复制以及维持神经元存活所必需的。